推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

MOLECULAR CANCER THERAPEUTICS

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 MOL CANCER THER最新评论:您好,我想请教一下您这个期刊的收费规则。oa是只用缴纳oa的费用还是也要缴纳出版费?出版费是不是基本出版费和图片的费用叠加?... (2024-09-29)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
出版社推荐:
美国化学会ACS期刊一览
IF 2.9,JCR Q2 神经系统基础研究期刊征稿中
开放获取选刊时如何避雷?点击查看干货指南!
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


MOLECULAR CANCER THERAPEUTICS期刊基本信息Hello,您是该期刊的第79959位访客


基本信息 登录收藏
期刊名字MOLECULAR CANCER THERAPEUTICSMOLECULAR CANCER THERAPEUTICS

MOL CANCER THER
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
7.9
51人评分
我要评分

声誉
8.8

影响力
6.7

速度
9.6

期刊ISSN1535-7163
微信扫码收藏此期刊
E-ISSN1538-8514
2023-2024最新影响因子
(数据来源于搜索引擎)
5.3 点击查看影响因子趋势图
实时影响因子 截止2024年10月29日:3.856
2023-2024自引率0.00%点击查看自引率趋势图
五年影响因子5.4
JCI期刊引文指标 1.23
h-index 157
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
11.202.2701.016
学科分区排名百分位
大类:Medicine
小类:Oncology
Q148 / 404
大类:Medicine
小类:Cancer Research
Q141 / 230

期刊简介
Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology. The journal provides a publication forum for these emerging disciplines that is focused specifically on cancer research. Papers are stringently reviewed and only those that report results of novel, timely, and significant research and meet high standards of scientific merit will be accepted for publication.
期刊官方网站http://mct.aacrjournals.org/
期刊投稿网址http://mct.msubmit.net/cgi-bin/main.plex
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足MOLECULAR CANCER THERAPEUTICS的语言要求,还能让MOLECULAR CANCER THERAPEUTICS编辑和审稿人得到更好的审稿体验,让稿件最大限度地被MOLECULAR CANCER THERAPEUTICS编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(1篇)
提交文稿
是否OA开放访问No
通讯方式AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404
出版商American Association for Cancer Research Inc.
涉及的研究方向医学-肿瘤学
出版国家或地区UNITED STATES
出版语言English
出版周期Monthly
出版年份2001
年文章数 116点击查看年文章数趋势图
Gold OA文章占比32.75%
研究类文章占比:
文章 ÷(文章 + 综述)
89.66%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:ONCOLOGYSCIEQ161/322
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:ONCOLOGYSCIEQ158/322
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区2区2区
ONCOLOGY
肿瘤学
2区3区2区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区4区
ONCOLOGY
肿瘤学
1区3区2区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区4区
ONCOLOGY
肿瘤学
3区3区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1535-7163%5BISSN%5D
平均审稿速度网友分享经验:
平均3月
平均录用比例网友分享经验:
约50%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在MOLECULAR CANCER THERAPEUTICS顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 MOLECULAR CANCER THERAPEUTICS期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 MOLECULAR CANCER THERAPEUTICS中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
MOLECULAR CANCER THERAPEUTICS上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    Nature Reviews Clinical Oncology12799.40
    NATURE REVIEWS CANCER396111.90
    ANNALS OF ONCOLOGY21063.90
    CANCER CELL29555.20
    JOURNAL OF CLINICAL ONCOLOGY49441.20
    LANCET ONCOLOGY27462.10
    CANCER RESEARCH41116.10
    SEMINARS IN CANCER BIOLOGY13426.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH6718.20
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE682716
    BIOMATERIALS570441
    BIOMEDICINE & PHARMACOTHERAPY556180
    Frontiers in Pharmacology519742
    Journal of Materials Chemistry B513798
    Frontiers in Immunology496997
    COMPUTERS IN BIOLOGY AND MEDICINE479587
    JOURNAL OF ETHNOPHARMACOLOGY470623
    COLLOIDS AND SURFACES B-BIOINTERFACES441005
    Frontiers in Oncology439734
  •  

    MOLECULAR CANCER THERAPEUTICS MOLECULAR CANCER THERAPEUTICS
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Tinengotinib (TT-00420), a Novel Spectrum-Selective Small-Molecule Kinase Inhibitor, Is Highly Active Against Breast Cancer

    Author: Peng, Peng; Qiang, Xiaoyan; Li, Guoyu; Li, Lin; Ni, Shumao; Yu, Qi; Sourd, Laura; Marangoni, Elisabetta; Hu, Chao; Wang, Dong; Wu, Di; Wu, Frank
    Journal: MOLECULAR CANCER THERAPEUTICS. 2023; Vol. 22, Issue 2, pp. 205-214. DOI: 10.1158/1535-7163.MCT-22-0012
        PubMed      DOI
    2.Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer

    Author: Li, Chengxun; Zhang, Jiale; Wu, Qiming; Kumar, Anuj; Pan, Guihong; Kelvin, David J.
    Journal: MOLECULAR CANCER THERAPEUTICS. 2023; Vol. 22, Issue 3, pp. 306-316. DOI: 10.1158/1535-7163.MCT-22-0159
        PubMed      DOI
    3.Griseofulvin Radiosensitizes Non-Small Cell Lung Cancer Cells and Activates cGAS

    Author: Wang, Xing; Raman, Natasha; Lemtiri-Chlieh, Ghali; Chang, Jinhee; Jagtap, Shreya; Chowdhury, Dipanwita Dutta; Ballew, Matthew; Carrieri, Francesca Anna; Nguyen, Triet; Nugent, Katriana; Peck, Travis; Levine, Michelle S.; Chan, Aaron; Lam, Christine; Malek, Reem; Hoang, Tung; Phillips, Ryan; Cheng, ZhuoAn; Taparra, Kekoa; Connis, Nick; Hann, Christine L.; Holland, Andrew; Tran, Phuoc T.; Lafargue, Audrey; Wang, Hailun
    Journal: MOLECULAR CANCER THERAPEUTICS. 2023; Vol. 22, Issue 4, pp. 519-528. DOI: 10.1158/1535-7163.MCT-22-0191
        PubMed      DOI
    4.Bepotastine Sensitizes Ovarian Cancer to PARP Inhibitors through Suppressing NF-KB-Triggered SASP in Cancer-Associated Fibroblasts

    Author: Jin, Ping; Li, Xin; Xia, Yu; Li, Huayi; Li, Xiaoting; Yang, Zong-Yuan; Wang, Zhen; Xu, Cheng; Fang, Tian; Zhou, Dongchen; Xiong, Xiaoming; Wang, Si-Yuan; Xu, Sen; Gao, Qinglei
    Journal: MOLECULAR CANCER THERAPEUTICS. 2023; Vol. 22, Issue 4, pp. 447-458. DOI: 10.1158/1535-7163.MCT-22-0396
        PubMed      DOI
    5.Combined Effects of Suberoylanilide Hydroxamic Acid and Cisplatin on Radiation Sensitivity and Cancer Cell Invasion in Non-Small Cell Lung Cancer.

    Author: Feng J, Zhang S, Wu K, Wang B, Wong JY, Jiang H, Xu R, Ying L, Huang H, Zheng X, Chen X, Ma S.
    Journal: Mol Cancer Ther. 2016 May;15(5):842-53. doi: 10.1158/1535-7163.MCT-15-0445. Epub 2016 Feb 2.
        PubMed  
    6.Bortezomib Inhibits Giant Cell Tumor of Bone through Induction of Cell Apoptosis and Inhibition of Osteoclast Recruitment, Giant Cell Formation, and Bone Resorption.

    Author: Xu L, Luo J, Jin R, Yue Z, Sun P, Yang Z, Yang X, Wan W, Zhang J, Li S, Liu M, Xiao J.
    Journal: Mol Cancer Ther. 2016 May;15(5):854-65. doi: 10.1158/1535-7163.MCT-15-0669. Epub 2016 Feb 9.
        PubMed  
    7.Identification of a Small Molecule That Overcomes HdmX-Mediated Suppression of p53.

    Author: Karan G, Wang H, Chakrabarti A, Karan S, Liu Z, Xia Z, Gundluru M, Moreton S, Saunthararajah Y, Jackson MW, Agarwal MK, Wald DN.
    Journal: Mol Cancer Ther. 2016 Apr;15(4):574-82. doi: 10.1158/1535-7163.MCT-15-0467. Epub 2016 Feb 16.
        PubMed  
    8.Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.

    Author: Wan L, Sun M, Liu GJ, Wei CC, Zhang EB, Kong R, Xu TP, Huang MD, Wang ZX.
    Journal: Mol Cancer Ther. 2016 May;15(5):1082-94. doi: 10.1158/1535-7163.MCT-15-0707. Epub 2016 Feb 23.
        PubMed  
    9.Chikusetsusaponin IVa Butyl Ester (CS-IVa-Be), a Novel IL6R Antagonist, Inhibits IL6/STAT3 Signaling Pathway and Induces Cancer Cell Apoptosis.

    Author: Yang J, Qian S, Cai X, Lu W, Hu C, Sun X, Yang Y, Yu Q, Gao SP, Cao P.
    Journal: Mol Cancer Ther. 2016 Jun;15(6):1190-200. doi: 10.1158/1535-7163.MCT-15-0551. Epub 2016 Feb 29.
        PubMed  
    10.Expression of GRP78, Master Regulator of the Unfolded Protein Response, Increases Chemoresistance in Pancreatic Ductal Adenocarcinoma.

    Author: Gifford JB, Huang W, Zeleniak AE, Hindoyan A, Wu H, Donahue TR, Hill R.
    Journal: Mol Cancer Ther. 2016 May;15(5):1043-52. doi: 10.1158/1535-7163.MCT-15-0774. Epub 2016 Mar 3.
        PubMed  
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Living Reviews in Relativity069.90
    Living Reviews in Relativity7569.90
    Advanced Composites and Hybrid Materials026.00
    Kidney International Supplements2026.70
    Kidney International Supplements2426.70
    Wiley Interdisciplinary Reviews-Computational Molecular Science6228.90
    Military Medical Research038.40
    NUCLEIC ACIDS RESEARCH45227.10
    Environmental Chemistry Letters5032.00
    Journal of the National Comprehensive Cancer Network8820.20
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共65


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室